BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36451374)

  • 21.
    Arponen O; McLean MA; Nanaa M; Manavaki R; Baxter GC; Gill AB; Riemer F; Kennerley AJ; Woitek R; Kaggie JD; Brackenbury WJ; Gilbert FJ
    Eur Radiol Exp; 2024 Jun; 8(1):75. PubMed ID: 38853182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aβ(42) induced MRI changes in aged rabbit brain resembles AD brain.
    Ramesh BN; Raichurkar KP; Shamasundar NM; Rao TS; Rao KS
    Neurochem Int; 2011 Oct; 59(5):637-42. PubMed ID: 21723897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease.
    Iaccarino L; Sala A; Caminiti SP; Presotto L; Perani D;
    J Alzheimers Dis; 2020; 75(3):1003-1016. PubMed ID: 32390614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease.
    Dincer A; Gordon BA; Hari-Raj A; Keefe SJ; Flores S; McKay NS; Paulick AM; Shady Lewis KE; Feldman RL; Hornbeck RC; Allegri R; Ances BM; Berman SB; Brickman AM; Brooks WS; Cash DM; Chhatwal JP; Farlow MR; la Fougère C; Fox NC; Fulham MJ; Jack CR; Joseph-Mathurin N; Karch CM; Lee A; Levin J; Masters CL; McDade EM; Oh H; Perrin RJ; Raji C; Salloway SP; Schofield PR; Su Y; Villemagne VL; Wang Q; Weiner MW; Xiong C; Yakushev I; Morris JC; Bateman RJ; L S Benzinger T;
    Neuroimage Clin; 2020; 28():102491. PubMed ID: 33395982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voxel-wise deviations from healthy aging for the detection of region-specific atrophy.
    Klöppel S; Yang S; Kellner E; Reisert M; Heimbach B; Urbach H; Linn J; Weidauer S; Andres T; Bröse M; Lahr J; Lützen N; Meyer PT; Peter J; Abdulkadir A; Hellwig S; Egger K;
    Neuroimage Clin; 2018; 20():851-860. PubMed ID: 30278372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.
    Tosun D; Mojabi P; Weiner MW; Schuff N
    Neuroimage; 2010 Aug; 52(1):186-97. PubMed ID: 20406691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains.
    Giulietti G; Bozzali M; Figura V; Spanò B; Perri R; Marra C; Lacidogna G; Giubilei F; Caltagirone C; Cercignani M
    Neuroimage; 2012 Jan; 59(2):1114-22. PubMed ID: 21983184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.
    Ho AJ; Hua X; Lee S; Leow AD; Yanovsky I; Gutman B; Dinov ID; Leporé N; Stein JL; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2010 Apr; 31(4):499-514. PubMed ID: 19780044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI.
    Petrone PM; Casamitjana A; Falcon C; Artigues M; Operto G; Cacciaglia R; Molinuevo JL; Vilaplana V; Gispert JD;
    Alzheimers Res Ther; 2019 Aug; 11(1):72. PubMed ID: 31421683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging the aging brain: study design and baseline findings of the SENIOR cohort.
    Haeger A; Mangin JF; Vignaud A; Poupon C; Grigis A; Boumezbeur F; Frouin V; Deverre JR; Sarazin M; Hertz-Pannier L; Bottlaender M;
    Alzheimers Res Ther; 2020 Jun; 12(1):77. PubMed ID: 32591008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
    Nicastro N; Malpetti M; Cope TE; Bevan-Jones WR; Mak E; Passamonti L; Rowe JB; O'Brien JT
    J Alzheimers Dis; 2020; 76(1):331-340. PubMed ID: 32444550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium MR imaging detection of mild Alzheimer disease: preliminary study.
    Mellon EA; Pilkinton DT; Clark CM; Elliott MA; Witschey WR; Borthakur A; Reddy R
    AJNR Am J Neuroradiol; 2009 May; 30(5):978-84. PubMed ID: 19213826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease.
    Silhan D; Pashkovska O; Bartos A;
    J Alzheimers Dis; 2021; 84(3):1259-1266. PubMed ID: 34633317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.
    Cavedo E; Suppa P; Lange C; Opfer R; Lista S; Galluzzi S; Schwarz AJ; Spies L; Buchert R; Hampel H; ;
    J Alzheimers Dis; 2017; 60(1):151-164. PubMed ID: 28777748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The feasibility of quantitative MRI of perivascular spaces at 7T.
    Cai K; Tain R; Das S; Damen FC; Sui Y; Valyi-Nagy T; Elliott MA; Zhou XJ
    J Neurosci Methods; 2015 Dec; 256():151-6. PubMed ID: 26358620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.